Inventor · disambiguated record
Sunil Paliwal
Also filed as: PALIWAL SUNIL
28 granted patents·17 pending applications·289 citations·filing 2000–2024
97Inventor score
Top patents by PatentIndex Score
45 records- 0194US7049320B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted May 23, 2006·54 cites·17 claims
- 0294US6635630B2Selective neurokinin antagonistsSCHERING CORP·Filed 2002·Granted Oct 21, 2003·41 cites·9 claims
- 0392US7902366B2NK1 antagonistsOPKO HEALTH INC·Filed 2006·Granted Mar 8, 2011·19 cites·19 claims
- 0492US7709641B2NK1 antagonistsOPKO HEALTH INC·Filed 2005·Granted May 4, 2010·20 cites·30 claims
- 0591US11261192B2Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Mar 1, 2022·5 cites·27 claims
- 0690US8178550B2Hydrochloride salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process thereforHU MENGWEI·Filed 2007·Granted May 15, 2012·17 cites·23 claims
- 0789US8026364B2NK1 antagonistsOPKO HEALTH INC·Filed 2010·Granted Sep 27, 2011·11 cites·39 claims
- 0888US8796299B2NK1 antagonistsOPKO HEALTH INC·Filed 2012·Granted Aug 5, 2014·9 cites·15 claims
- 0988US8470842B2Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process thereforHU MENGWEI·Filed 2009·Granted Jun 25, 2013·13 cites·16 claims
- 1087US8273895B2NK1 antagonistsPALIWAL SUNIL·Filed 2010·Granted Sep 25, 2012·12 cites·3 claims
- 1187US6436928B1Selective neurokinin antagonistsSCHERING CORP·Filed 2000·Granted Aug 20, 2002·17 cites·23 claims
- 1286US8546404B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2007·Granted Oct 1, 2013·9 cites·76 claims
- 1384US8754216B2NK1 antagonistsSHAH SAPNA S·Filed 2011·Granted Jun 17, 2014·9 cites·38 claims
- 1484US7122677B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted Oct 17, 2006·26 cites·23 claims
- 1582US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 1680US2024391924A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1779US11124518B2L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Sep 21, 2021·2 cites·22 claims
- 1879US7354922B2Bridged ring NK1 antagonistsSCHERING CORP·Filed 2005·Granted Apr 8, 2008·4 cites·30 claims
- 1978US9469629B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Oct 18, 2016·2 cites·12 claims
- 2078US8552191B2Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsMERGELSBERG INGRID·Filed 2008·Granted Oct 8, 2013·6 cites·11 claims
- 2173US8716483B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2009·Granted May 6, 2014·2 cites·12 claims
- 2271US9169260B2Amidopyrazole inhibitors of interleukin receptor-associated kinasesMCELROY WILLIAM T·Filed 2012·Granted Oct 27, 2015·4 cites·7 claims
- 2369US12054479B1Multicyclic compoundsSLAP PHARMACEUTICALS LLC·Filed 2024·Granted Aug 6, 2024·0 cites·4 claims
- 2469US9260428B2Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsOPKO HEALTH INC·Filed 2013·Granted Feb 16, 2016·1 cites·9 claims
- 2569US2022024939A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 2666US8623857B2N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1TSUI HON-CHUNG·Filed 2011·Granted Jan 7, 2014·1 cites·18 claims
- 2764US9688693B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Jun 27, 2017·0 cites·8 claims
- 2864US2018215729A1Nk 1 antagonistsOPKO HEALTH INC·Filed 2018·Application pending·0 cites
- 2962US9969711B2NK1 antagonistsOPKO HEALTH INC·Filed 2016·Granted May 15, 2018·0 cites·6 claims
- 3062US2021317124A11,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 3162US2019375751A1Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process thereforOPKO HEALTH INC·Filed 2019·Application pending·0 cites
- 3261US2017283434A1Nk1 antagonistsOPKO HEALTH INC·Filed 2017·Application pending·0 cites
- 3359US2013281477A1Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process thereforOPKO HEALTH INC·Filed 2013·Application pending·0 cites
- 3459US2025214980A1Multicyclic compoundsSLAP PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 3556US10196394B2Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process thereforOPKO HEALTH INC·Filed 2015·Granted Feb 5, 2019·0 cites·20 claims
- 3654US10000493B2Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsOPKO HEALTH INC·Filed 2016·Granted Jun 19, 2018·0 cites·1 claims
- 3748US2010068181A1Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activitySCHERING CORP·Filed 2007·Application pending·0 cites
- 3847US2023192720A1Macrocyclic compoundsZENO MAN INC·Filed 2020·Application pending·0 cites
- 3947US2011038876A1Heterocyclic compounds and use thereof as erk inhibitorsSUN ROBERT·Filed 2008·Application pending·0 cites
- 4046US2022144854A1Macrocyclic compoundsZENO MAN INC·Filed 2020·Application pending·0 cites
- 4141US2007191604A1Novel compounds that are ERK inhibitorsCOOPER ALAN·Filed 2006·Application pending·0 cites
- 4241US2006247320A1Compounds for inhibiting KSP kinesin activitySCHERING CORP·Filed 2006·Application pending·0 cites
- 4340US2006281778A1Compounds for inhibiting KSP Kinesin activitySCHERING CORP·Filed 2006·Application pending·0 cites
- 4434US2013165450A1Novel Thiazol-Carboximide Derivatives as PDK1 InhibitorsTSUI HON-CHUNG·Filed 2011·Application pending·0 cites
- 4533US2013053382A1Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1)PALIWAL SUNIL·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →